I have no near term expectations about price...my sense is that it is "cheap" now. But...they have an approved drug that is going to be used over time with ever more frequency (+ chance for expanded labeling). They have a great partner. This may take some time but I think they are on a good path.....There are some good upside possibilities and the existing product might be worth the partner's purchase. I hope they stay the path...I have added to (and will keep) what shares I have. I think this is an "investment". Worth the chance...IMO.